Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Gillian Patman.

Newcastle AuthorsTitleYearFull text
Marco Zaki
Dr Ahmed Mahdi
Dr Gillian Patman
Anna Whitehead
Joao Mauricio
et al.
Key features of the environment promoting liver cancer in the absence of cirrhosis2021
Dr Ziad Al-Oanzi
Sofia Fountana
Tabassum Moonira
Dr Susan Tudhope
John Petrie
et al.
Opposite effects of a glucokinase activator and metformin on glucose-regulated gene expression in hepatocytes2017
Dr Richard Speight
Anna Whitehead
Dr Gillian Patman
Dr John Mansfield
Professor Helen Reeves
et al.
Activation of the bile acid receptor, Farnesoid-X Receptor, may reduce Ileal Inflammatory Cytokine expression in an animal model of diet-induced obesity2015
Anna Whitehead
Dr Gillian Patman
Professor Chris Day
Dr Dina Tiniakos
Professor Quentin Anstee
et al.
Effects of FXR agonist PX20606 on tumour formation in animal models of non-alcoholic fatty liver disease2015
Anna Whitehead
Laura Ogle
Dr Gillian Patman
Dr Ali Anwar
Dr Dina Tiniakos
et al.
Ras and p-ERK in metabolic syndrome associated Hepatocellular Carcinoma (HCC)2015
Dr Yang-Lin Liu
Dr Gillian Patman
Julian Leathart
Professor Alastair Burt
Professor Chris Day
et al.
Carriage of the PNPLA3 rs738409 C>G Polymorphism Confers an Increased Risk of Non-Alcoholic Fatty Liver Disease Associated Hepatocellular Carcinoma2014
Dr Gillian Patman
Professor Helen Reeves
The Detection of Hepatocellular Carcinoma Using a Prospectively Developed and Validated Model Based on Serological Biomarkers2014
Anna Whitehead
Dr Gillian Patman
Liam Cornell
Dr Despina Televantou
Professor Nicola Curtin
et al.
A Role for DNA Repair Protein Kinase (DNA-PK) in the Progression of Simple Steatosis to Steatohepatitis (NASH)?2013
Dr Yang-Lin LIU
Dr Gillian Patman
Julian Leathart
Professor Alastair Burt
Professor Chris Day
et al.
Carriage of PNPLA3 I148M is Associated with an Increased Risk of Non-Alcoholic Fatty Liver Disease Associated Hepatocellular Carcinoma2013
Dr Gillian Patman
Dr Despina Televantou
Anna Whitehead
Professor Chris Day
Professor Fiona Oakley
et al.
Mild Steatosis and Impaired Glucose Tolerance are Associated with Liver Cancer Development, While Progression to Nash Increases Number/Size in an Animal Model of NAFLD2013
Dr Gillian Patman
Professor Loranne Agius
Douglas Hui
Dr Despoina Televantou
Professor Helen Reeves
et al.
Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis2013
Dr Gillian Patman
Dr Despina Televantou
Anna Whitehead
Professor Chris Day
Professor Alastair Burt
et al.
Sulfatase-2 (SULF2) Expressed in Hepatocytes and Stromal Cells Contributes to the Development of Steatosis, the Progression of NAFLD to Fibrosis and the Advancement of Cancer2013
John Petrie
Dr Gillian Patman
Ishita Sinha
Professor Helen Reeves
Professor Loranne Agius
et al.
The rate of production of uric acid by hepatocytes is a sensitive index of compromised cell ATP homeostasis2013
Dr Gillian Patman
Laura Pascoe
Dr Luca Miele
Douglas Hui
Professor Alastair Burt
et al.
Glucokinase links Kr├╝ppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease2012
Douglas Hui
Stuart Robinson
Dr Gillian Patman
Professor Derek Manas
Professor Helen Reeves
et al.
KLF6 splice variant 1 in patients with colorectal liver metastasis correlates with a higher clinical risk score2012
Dr Gillian Patman
Douglas Hui
Professor Quentin Anstee
Professor Helen Reeves
Kruppel-like factor 6 splice variant 3 (KLF6-SV3) - The redox sensitive splice variant of KLF6 expressed in non-alcoholic steatohepatitis (NASH)2012
Dr Gillian Patman
Douglas Hui
Professor Quentin Anstee
Professor Helen Reeves
Oxidative stress induces alternative splicing and nuclear translocation of kruppel like factor 62012
Dr Gillian Patman
Professor Quentin Anstee
Professor Helen Reeves
Hepatocellular Carcinoma in NASH: Is there a biological Rationale?2011
Dr Gillian Patman
Professor Loranne Agius
Professor Helen Reeves
Liver-specific deletion of KLF6 uncovers novel transcriptional pathways linked to lipid and glucose homeostasis2010
Dr Joseph Gray
Dr Dipanker Chattopadhyay
Dr Gary Beale
Dr Gillian Patman
Dr Luca Miele
et al.
A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease2009
Dr Gary Beale
Ahmad Alserri
Dr Luca Miele
Dr Gillian Patman
Professor Ann Daly
et al.
Claudin 10 (CLDN10) - a Candidate Suceptibility Gene for NAFLD Progression2009
Dr Gillian Patman
Professor Helen Reeves
Kruppel-like factor 6 in chronic liver disease and hepatocellular cancer2009
Dr Luca Miele
Dr Gary Beale
Dr Gillian Patman
Julian Leathart
Professor Chris Day
et al.
The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease2008